Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$284K Buy
3,545
+372
+12% +$28.5K 0.03% 101
2019
Q1
$252K Sell
3,173
-5,238
-62% -$392K 0.02% 104
2018
Q4
$613K Sell
8,411
-6,794
-45% -$480K 0.05% 98
2018
Q3
$1.03M Buy
15,205
+305
+2% +$19.4K 0.07% 61
2018
Q2
$863K Sell
14,900
-34
-0.2% -$1.92K 0.12% 54
2018
Q1
$776K Sell
14,934
-625
-4% -$33.8K 0.1% 66
2017
Q4
$835K Buy
15,559
+9,498
+157% +$527K 0.05% 83
2017
Q3
$370K Buy
6,061
+230
+4% +$13.9K 0.03% 79
2017
Q2
$357K Sell
5,831
-131
-2% -$7.97K 0.03% 77
2017
Q1
$361K Buy
5,962
+1,838
+45% +$112K 0.03% 73
2016
Q4
$232K Buy
+4,124
New +$241K 0.02% 88
2014
Q2
Sell
-6,054
Closed -$328K 112
2014
Q1
$328K Buy
+6,054
New +$313K 0.04% 73

Other funds holding MRK

Lourd Capital's MRK Position: Q2 2019 in Review

Lourd Capital increased its Merck (MRK) stake by 12% in Q2 2019, buying an estimated $28.5K and bringing the position to 3,545 shares worth $284K. The position accounts for 0.03% of the portfolio, ranked #101.

Lourd Capital first reported a position in MRK in Q1 2014 and has held it in 12 quarters since. The position peaked at $1.03M in Q3 2018. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Lourd Capital held 3,545 shares of Merck worth $284K as of Q2 2019.
  • Lourd Capital bought 372 Merck shares in Q2 2019, an estimated $28.5K.
  • Merck made up 0.03% of Lourd Capital's portfolio in Q2 2019, its #101 holding.
  • Lourd Capital first reported a position in Merck in Q1 2014 and has held it in 12 quarters since.
  • Lourd Capital's Merck position peaked at $1.03M in Q3 2018.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Lourd Capital's 13F filing for Q2 2019, filed 11 Jul 2019.